Undervalued Microcap at <10% of BUD mcap, page-3

It was IPO at $1 valuing the company at about $85m. Technology is great from CSIRO and good pedigree shareholders so they had good support for that valuation then. But in hindsight, possibly valued at too high a valuation for a company that is still in negative cashflow.
Too much focus on the historics (e.g cash burn etc) by long timers but should be looking forwards IMO ....I am looking purely at valuation vis-a-vis its revenue and I can safely say you can see BIQ's revenues in 4C unlike BUD. Of course, comparing the company to BUD suggest its undervaluation does not mean it should rise to BUD's level but it is to put things into perspective. Fact is BUD is loved while BIQ is yet to be in a big way.

Many other tech companies yet to produce revenues let alone cashflow positive and already commanding substantially higher mcap- take BTH as example, 20c with mcap of $35m when I first highlighted, now 43c with mcap of $75.8m and still not generating cashflow positive (but getting close). For long timers , I see those in TNT and M7T with complaints because they bought at IPO level (although M7T has improved substantially after new blood shareholders came in) and still substantially underwater so understandably lots of frustration. Sp may not get to IPO level but for now we are looking at today's paltry mcap level of just $14m! DYOR.